Yoshiro Kai Masanori Yoshikawa Masayuki Matsuda Kentaro Suzuki Masato Takano Kazuya Tanimura Nobuhiro Fujioka Yukio Fujita Shigeo Muro
10.1016/j.rmcr.2022.101723
Respir Med Case Rep
2022 Aug 17;39:101723.
abpa, allergic bronchopulmonary aspergillosis act, asthma control test anca, antineutrophil cytoplasmic antibody allergic bronchopulmonary aspergillosis ct, computed tomography dupilumab eetosis, eosinophil extracellular trap cell death etosis, extracellular trap cell death fev1, forced expiratory volume in 1 sec ics, inhaled corticosteroid il-13 il-4 il-5, interleukin-5 ilc2, group-2 innate lymphoid cells ige, immunoglobulin e laba, long-acting beta-agonist mepolizumab psl, prednisolone prednisolone
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/36043197/
Case Reports
PMC9420510
36043197
Successful management of recurrent allergic bronchopulmonary aspergillosis after changing from mepolizumab to dupilumab: A case report
2022